A recent report published by Infinium
Global Research on cough hypersensitivity syndrome treatment market provides an
in-depth analysis of segments and sub-segments in the global as well as
regional cough hypersensitivity syndrome treatment market. The study also
highlights the impact of drivers, restraints, and macro indicators on the
global and regional cough hypersensitivity syndrome treatment market over the
short term as well as long term. The report is a comprehensive presentation of
trends, forecast and dollar values of global cough hypersensitivity syndrome
treatment market. According to the report, the global cough hypersensitivity
syndrome treatment market is projected to grow at a CAGR of 5.9% over the
forecast period of 2019-2025.
Cough
hypersensitivity syndrome relates to cough related conditions due to exposure
to certain mechanical, thermal, and chemical environments. The treatment for
this syndrome prescribes the consumption of different classes of drugs that are
mainly effective for three causes of chronic cough.
The rising
prevalence of chronic respiratory diseases worldwide contributes to the growth
of the cough hypersensitivity syndrome treatment market. Among all chronic
respiratory diseases, COPD affects more than 200 million people in the world
and 65 million of them have moderate or severe airway disease. Moreover, the
growing chronic cough conditions and a surge in the number of smokers globally
promote the demand of the market. Cigarettes are smoked by over 1 billion
people worldwide which is around 20% of the world’s population in 2014. Smoking
rates are declining in developed nations. But still, smoking is a concern for
respiration related diseases. In addition, the growing prevalence of chronic
cough associated with Gastroesophageal Reflux Disease stimulates the growth of
the cough hypersensitivity syndrome treatment market. As per the World
Gastroenterology Organization, the prevalence rate of Gastroesophageal Reflux
Disease is rising rapidly across the world. On the other side, limited efficacy
and undesirable side effects of antitussives hamper the growth of the market.
Moreover, the surge in research and development activities in the treatment of
cough hypersensitivity syndrome creates numerous opportunities for the growth
of the cough hypersensitivity syndrome treatment market.
North
America is anticipated to hold a premium share in the global cough
hypersensitivity syndrome treatment market. The prevalence of chronic
respiratory diseases in North America drives the growth of the market in this
region. Asia-Pacific region is expected to grow in the global cough
hypersensitivity syndrome treatment market owing to the growing pollution
levels and an increasing number of patients with unexplained chronic cough. As
per the World Health Organization, air pollution levels in the Asia-Pacific region is dangerously high. There are around 2.2 million air pollution-related
deaths in the region in 2016 and 22% of them are due to chronic obstructive
pulmonary disease (COPD). Furthermore, the rising respiratory disorders are
leading the growth of the market in Europe. In 2016, the EU has 82.7 deaths per
100000 inhabitants due to respiratory diseases.
The report on global cough
hypersensitivity syndrome treatment market covers segments such as drug class
and distribution channel. On the basis of drug class, the sub-markets include
inhales corticosteroids, antitussive agents, short-acting beta-2 agonists,
anticholinergics, proton pump inhibitors, antihistamines, and other drug
classes. On the basis of the distribution channel, the sub-markets include
hospital pharmacies, retail pharmacies, and online pharmacies.
The report provides profiles of the
companies in the market such as Merck & Co., Inc., Pfizer, Inc.,
GlaxoSmithKline plc, AstraZeneca plc, F. Hoffmann-La Roche AG, Teva
Pharmaceutical Industries Ltd., Novartis AG, Johnson & Johnson Consumer
Inc., Vertex Pharmaceuticals, Inc., Boehringer Ingelheim GmbH, and other
companies.
The report provides deep insights into
the demand forecasts, market trends, and micro and macro indicators. In
addition, this report provides insights into the factors that are driving and
restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis
given in the report brings an insight into the investment areas that existing
or new market players can consider. The report provides insights into the
market using analytical tools such as Porter's five forces analysis and DRO
analysis of cough hypersensitivity syndrome treatment market. Moreover, the
study highlights current market trends and provides forecast from 2019-2025. We
also have highlighted future trends in the market that will affect the demand
during the forecast period. Moreover, the competitive analysis given in each
regional market brings an insight into the market share of the leading players.
Please Choose One of them.